Large gap with delayed quotes
Analysis date: 14.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 19.09.2025.
Interest
Very strong
Very strong
Four stars since 19.09.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 19.09.2025 at a price of 267.95.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 17.06.2025.
4wk Rel Perf
22.12%
22.12%
The four-week dividend-adjusted overperformance versus STOXX600 is 22.12%.
Sensibility
High
High
High, no change over 1 year.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.61%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.77%.
Mkt Cap in $bn
43.02
43.02
With a market capitalization >$8bn, KERING is considered a large-cap stock.
G/PE Ratio
1.11
1.11
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of
LT P/E
25.89
25.89
The estimated PE is for the year 2027.
LT Growth
27.31%
27.31%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
21
21
Over the last seven weeks, an average of 21 analysts provided earnings per share estimates.
Dividend Yield
1.34%
1.34%
The twelve month estimated dividend yield represents 34.55% of earnings forecasts.
Beta
90
90
For 1% of index variation, the stock varies on average by 0.90%.
Correlation
0.31
0.31
Stock movements are strongly independent of index variations.
Value at Risk
88.57
88.57
The value at risk is estimated at EUR 88.57. The risk is therefore 29.63%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002